An observational study in Primary Graft Dysfunction, sponsored by University Hospital of Mont-Godinne. Completed at 1 site in Belgium. Open to participants aged 5 Years to 70 Years. Per ClinicalTrials.gov, last updated 2016-03-15.
Sponsored by University Hospital of Mont-Godinne · Observational
Primary graft dysfunction, a form of reperfusion pulmonary edema that occurs early after lung transplantation, shares key clinical and pathological features with acute lung injury and its more severe form, the acute respiratory distress syndrome. However, in contrast to acute lung injury/acute respiratory distress syndrome, in which biomarkers in plasma, urine and lung edema fluid have prognostic and pathogenetic value, the role of biomarkers in primary graft dysfunction has been less thoroughly explored. We will try in this study de determine the rule of pneumoproteins in the donor organ on the pulmonary edema in the recipient.
Organ donors and lung recipients
All the organ donors for lung grafts.
Exclusion Criteria:
none
Non Heart Beating Donors
Other: no intervention
Brain death donors
Other: no intervention
Number of Recipient with primary graft dysfunction
Time frame: one year
This study is completed, as verified in Mar 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital of Mont-Godinne